Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Tolerogenic Immune-Modifying Nanoparticles Encapsulating Multiple Recombinant Pancreatic β Cell Proteins Prevent Onset and Progression of Type 1 Diabetes in Nonobese Diabetic Mice

The Journal of Immunology(2022)10.4049/jimmunol.2200208Source: DataRank Database

Tolerogenic Immune-Modifying Nanoparticles Encapsulating Multiple Recombinant Pancreatic β Cell Proteins Prevent Onset and Progression of Type 1 Diabetes in Nonobese Diabetic Mice is a research paper published in The Journal of Immunology (2022). On theSindex it has a DataRank of 0. It has been cited 34 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access34 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 3.87)OA: bronzeTopics (49)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Samantha Genardi ORCID,Ming‐Yi Chiang,Sandeep Kakade ORCID,Tobias Neef ORCID,Tushar Murthy

Live enrichment

PubMed:35725270 PMC:PMC9339508 OpenAlex:https://openalex.org/W4283277410

HHS | National Institutes of Health

Grant: R01 AI155678

Juvenile Diabetes Research Foundation United States of America

Grant: 2-SRA-2018-566-S-B

Juvenile Diabetes Research Foundation United States of America

Grant: 3-PDF-2018-582-A-N

Cour Pharmaceutical Development Company, Inc.

Grant: 02-14-2022-4

NIBIB NIH HHS

Grant: R01 EB013198

NINDS NIH HHS

Grant: R01 NS099334

National Institutes of Health

Grant: 5R01AI155678-04

Allergen Loaded Nanoparticles for Food Allergy Tolerance

FWCI

3.87

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

bronzeLicense: OUP Standard Publication Reuse

journalhttps://journals.aai.org/jimmunol/article-pdf/209/3/465/1487460/ji2200208.pdf

publisherhttps://journals.aai.org/jimmunol/article-pdf/209/3/465/1487460/ji2200208.pdf

publisherhttps://academic.oup.com/jimmunol/article-pdf/209/3/465/61467930/ji2200208.pdf

journalhttps://doi.org/10.4049/jimmunol.2200208

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35725270

Fields of Study

Diabetes and associated disordersPancreatic function and diabetesDiabetes Management and Research0301 basic medicine0303 health sciences03 medical and health sciencesAnimalsDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 1EpitopesInsulinInsulin-Secreting CellsMiceMice, Inbred NODMice, SCIDNanoparticlesProteins

MeSH Terms

AnimalsEpitopesDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 1InsulinProteinsMice, SCIDMice, Inbred NODInsulin-Secreting CellsMiceNanoparticles

Keywords

Recombinant DNAImmune systemCellDiabetes mellitusChemistryCancer researchImmunologyMedicineEndocrinologyBiochemistryProteinsMice, SCIDDiabetes Mellitus, ExperimentalEpitopesMiceDiabetes Mellitus, Type 1Mice, Inbred NODInsulin-Secreting CellsAnimalsInsulinNanoparticles

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being